A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals

Molecular Psychiatry

Volumn 4, Issue 2, 1999, Pages 173-178

  Edgar, P F ^a   Schonberger, S J ^a   Dean, B ^c   Faull, R L M ^b   Kydd, R ^b   Cooper, G J S ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c NONE

Author keywords

Brain mapping; GABA A receptors; Nerve degeneration; Prefrontal cortex; Two dimensional gel electrophoresis

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DIAZEPAM BINDING INHIBITOR; GENE PRODUCT; PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOPSY; BRAIN MAPPING; CLINICAL ARTICLE; GEL ELECTROPHORESIS; GENOME; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MENTAL DISEASE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCHIZOPHRENIA; SEQUENCE ANALYSIS;

EID: 0032915003     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000463     Document Type: Article

References (29)

1. Wasinger VC, Cordwell SJ, Cerpa-Poljak A, Yan JX, Gooley AA, Wilkins MR et al. Progress with gene-product mapping of the Mollicules: mycoplasma genitalium. Electrophoresis 1995; 16: 1090-1094.
2. Humphery-Smith I, Cordwell SJ, Blackstock WP. Proteome research: complementarity and limitations with respect to the RNA and DNA worlds. Electrophoresis 1997; 18: 1217-1242.
3. Costa E, Guidotti A. Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Life Sci 1991; 49: 325-344.
4. Knudsen J, Mandrup S, Rasmussen JT, Andreasen PH, Poulsen F, Kristiansen K. The function of acyl-CoA-binding protein (ACBP)/diazepam binding inhibitor (DBI). Mol & Cell Biochem 1993; 23: 129-138.
5. Owen MJ, Holmans P, McGuffin P. Association studies in psychiatric genetics. Mol Psychiatry 1997; 2: 270-273.
6. Yan JX, Tonella L, Sanchez J, Wilkins MR, Packer NH, Gooley AA et al. The Dictyostelium discoideum proteome - the SWISS 2DPAGE database of the multicellular aggregate (slug). Electrophoresis 1997; 18: 491-497.
7. Wilkins MR, Williams KL, Appel RD, Hochstrasser DF (eds). Proteome Research: New Frontiers in Functional Genomics. Springer Verlag: Berlin Heidelberg, 1997, p 243.
8. Pleissner K, Soeding P, Sander S, Oswald H, Neuss M, Regitz-Zagrosek V et al. Dilated cardiomyopathy-associated proteins and their presentation in a WWW-accessible two-dimensional gel protein database. Electrophoresis 1997; 18: 802-808.
9. Hirano T, Franzen B, Uryu K, Okuzawa K, Alaiya AA, Vanky F et al. Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma. Br J Cancer 1995; 72: 840-848.
10. Dawbarn D, Allen SJ (eds). Molecular and Cellular Neurobiology: Neurobiology of Alzheimers Disease. Bios Scientific Publishers: Oxford, 1995.
11. Weinberger DR. Schizophrenia. From neuropathology to neurodevolopment. Lancet 1995; 346: 552-557.
12. Miyala M, Mocchetti I, Ferrarese C, Guidotti A, Costa E. Protracted treatment with diazepam increases the turnover of putative endogenous ligands for the benzodiazepine/beta-carboline recognition site. Proc Natl Acad Sci USA 1987; 84: 1444-1448.
13. Lihrmann I, Plaquevent JC, Tostivint H, Raijmakers R, Tonon MC, Conlon JM et al. Frog diazepam-binding inhibitor: peptide sequence, cDNA cloning, and expression in the brain. Proc Natl Acad Sci USA 1994; 91: 6899-6903.
14. Ball S, Busatto GF, David AS, Jones SH, Hemsley DR, Pilowsky LS et al. Cognitive functioning and GABA(A)/benzodiazepine receptor binding in schizophrenia - a I-123-iomazenil SPET study. Biol Psychiatry 1998; 43: 107-117.
15. Van Kammen DP, Guidotti A, Kelley ME, Gurklis J, Guarneri P, Gilbertson MW et al. CSF diazepam binding inhibitor and schizophrenia: clinical and biochemical relationship. Biol Psychiatry 1993; 34: 515-522.
16. Van Kammen DP, Guidotti A, Neylan T, Guarneri P, Kelley ME, Curklis J et al. CSF levels of diazepam-binding inhibitor correlate with REM latency in schizophrenia, a pilot study. Eur Arch Psychiatry & Clin Neurosci 1994; 244: 216-222.
17. Ferrarese C, Appollonio I, Frigo M, Meregalli S, Piolti R, Tamma F et al. Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia. Neurology 1990; 40: 632-635.
18. Sudath RL, Christison GW, Torrey EF, Weinberger DR. Cerebral anatomical abnormalities in monozygotic twins discordant for schizophrenia. N Engl J Med 1990; 332: 789-794.
19. DeLisi LE, Hoff AL, Schwartz JE, Shields GW, Halthore SN, Gupta SM et al. Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biol Psychiatry 1991; 129: 159-175.
20. Degreef G, Ashtari M, Bogerts B, Bilder RM, Jody D, Alvir JMJ et al. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry 1992; 49: 531-537.
21. Reveley AM, Reveley MA, Clifford CA, Murray RM. Cerebral ventricular size in twins discordant for schizophrenia. Lancet 1982; ii: 540-541.
22. Bogerts B, Ashtari M, Degreef G, Alvir JMJ, Bilder RM. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res Neuroimaging 1990; 35: 1-13.
23. Andreasen NC, Flashman L, Flaum M, Arndt S, Swayze V, O'Leary DS et al. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA 1994; 272: 1763-1769.
24. Schlaepfer TE, Harris GJ, Tien AY, Peng LW, Lee S, Federman EB et al. Decreased regional cortical gray matter volume in schizophrenia. Am J Psychiatry 1994; 151: 842-848.
25. Arnold SE, Trojanowski JQ. Cognitive impairment in elderly schizophrenia: a dementia (still) lacking distinctive histopathology. Schizophrenia Bull 1996; 22: 5-9.
26. Arnold SE, Franz BR, Trojanowski JQ, Mobert PJ. Gur RE glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathologica 1996; 91: 269-277.
27. Dongre AR, Eng JK, Yates III JR. Emerging tandem-mass-spectrometry techniques for the rapid identification of proteins. TIB-TECH 1997; 15: 418-425.
28. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
29. Hubbard MJ. Calbindin28kDa and calmodulin are hyperabundant in rat dental enamel cells. Identification of the protein phosphatase calcineurin as a principal calmodulin target and of a secretion- related role for calbindin28kDa. Eur J Biochem 1995; 230: 68-79.